Annual EBITDA:
-$175.87M-$148.93M(-552.77%)Summary
- As of today, CDTX annual EBITDA is -$175.87 million, with the most recent change of -$148.93 million (-552.77%) on December 31, 2024.
- During the last 3 years, CDTX annual EBITDA has fallen by -$133.61 million (-316.21%).
- CDTX annual EBITDA is now -16154.07% below its all-time high of -$1.08 million, reached on December 31, 2013.
Performance
CDTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$43.60M-$12.31M(-39.33%)Summary
- As of today, CDTX quarterly EBITDA is -$43.60 million, with the most recent change of -$12.31 million (-39.33%) on September 30, 2025.
- Over the past year, CDTX quarterly EBITDA has dropped by -$26.27 million (-151.54%).
- CDTX quarterly EBITDA is now -391.44% below its all-time high of $14.96 million, reached on September 30, 2022.
Performance
CDTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$159.75M-$26.27M(-19.68%)Summary
- As of today, CDTX TTM EBITDA is -$159.75 million, with the most recent change of -$26.27 million (-19.68%) on September 30, 2025.
- Over the past year, CDTX TTM EBITDA has dropped by -$114.22 million (-250.90%).
- CDTX TTM EBITDA is now -28476.92% below its all-time high of -$559.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CDTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -552.8% | -151.5% | -250.9% |
| 3Y3 Years | -316.2% | -391.4% | -383.1% |
| 5Y5 Years | -321.5% | -149.8% | -149.3% |
CDTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -552.8% | at low | -391.4% | +19.4% | -6533.9% | at low |
| 5Y | 5-Year | -552.8% | at low | -391.4% | +19.4% | -6533.9% | at low |
| All-Time | All-Time | >-9999.0% | at low | -391.4% | +19.4% | >-9999.0% | at low |
CDTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$43.60M(-39.3%) | -$159.75M(-19.7%) |
| Jun 2025 | - | -$31.29M(-1.8%) | -$133.48M(-17.9%) |
| Mar 2025 | - | -$30.73M(+43.2%) | -$113.23M(-24.4%) |
| Dec 2024 | -$175.87M(-552.8%) | -$54.12M(-212.3%) | -$90.99M(-99.9%) |
| Sep 2024 | - | -$17.33M(-56.9%) | -$45.52M(-39.5%) |
| Jun 2024 | - | -$11.04M(-30.1%) | -$32.64M(-15.3%) |
| Mar 2024 | - | -$8.49M(+2.0%) | -$28.32M(-66.4%) |
| Dec 2023 | -$26.94M(+19.2%) | -$8.66M(-94.8%) | -$17.02M(+22.0%) |
| Sep 2023 | - | -$4.45M(+33.9%) | -$21.81M(-805.9%) |
| Jun 2023 | - | -$6.72M(-339.0%) | -$2.41M(+72.5%) |
| Mar 2023 | - | $2.81M(+120.9%) | -$8.76M(+70.6%) |
| Dec 2022 | -$33.36M(+21.1%) | -$13.46M(-190.0%) | -$29.80M(+9.9%) |
| Sep 2022 | - | $14.96M(+214.4%) | -$33.07M(+49.9%) |
| Jun 2022 | - | -$13.07M(+28.2%) | -$66.02M(-56.7%) |
| Mar 2022 | - | -$18.22M(-8.9%) | -$42.12M(-0.1%) |
| Dec 2021 | -$42.26M(+40.3%) | -$16.73M(+7.0%) | -$42.07M(+10.1%) |
| Sep 2021 | - | -$17.99M(-266.2%) | -$46.81M(-1.2%) |
| Jun 2021 | - | $10.82M(+159.6%) | -$46.28M(+38.5%) |
| Mar 2021 | - | -$18.16M(+15.4%) | -$75.24M(-5.1%) |
| Dec 2020 | -$70.80M(-69.7%) | -$21.48M(-23.1%) | -$71.56M(-11.7%) |
| Sep 2020 | - | -$17.45M(+3.8%) | -$64.08M(-47.2%) |
| Jun 2020 | - | -$18.14M(-25.2%) | -$43.52M(-10.0%) |
| Mar 2020 | - | -$14.49M(-3.5%) | -$39.57M(+4.4%) |
| Dec 2019 | -$41.72M | -$14.00M(-550.4%) | -$41.40M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $3.11M(+121.9%) | -$43.88M(+28.7%) |
| Jun 2019 | - | -$14.18M(+13.1%) | -$61.58M(+3.1%) |
| Mar 2019 | - | -$16.32M(+1.0%) | -$63.52M(+0.6%) |
| Dec 2018 | -$62.76M(-14.0%) | -$16.49M(-13.0%) | -$63.87M(-5.2%) |
| Sep 2018 | - | -$14.59M(+9.5%) | -$60.71M(-4.3%) |
| Jun 2018 | - | -$16.13M(+3.3%) | -$58.22M(+0.5%) |
| Mar 2018 | - | -$16.67M(-25.2%) | -$58.52M(-6.3%) |
| Dec 2017 | -$55.05M(-15.4%) | -$13.32M(-10.0%) | -$55.05M(+1.5%) |
| Sep 2017 | - | -$12.11M(+26.3%) | -$55.90M(+0.1%) |
| Jun 2017 | - | -$16.43M(-24.5%) | -$55.95M(-9.3%) |
| Mar 2017 | - | -$13.20M(+6.8%) | -$51.20M(-7.3%) |
| Dec 2016 | -$47.70M(-49.8%) | -$14.17M(-16.5%) | -$47.70M(-10.2%) |
| Sep 2016 | - | -$12.16M(-4.2%) | -$43.29M(-7.6%) |
| Jun 2016 | - | -$11.67M(-20.3%) | -$40.24M(-15.2%) |
| Mar 2016 | - | -$9.71M(+0.5%) | -$34.92M(-9.6%) |
| Dec 2015 | -$31.85M(-223.8%) | -$9.76M(-7.1%) | -$31.85M(-19.5%) |
| Sep 2015 | - | -$9.11M(-43.5%) | -$26.66M(-28.2%) |
| Jun 2015 | - | -$6.35M(+4.4%) | -$20.80M(-30.6%) |
| Mar 2015 | - | -$6.64M(-45.6%) | -$15.92M(-61.8%) |
| Dec 2014 | -$9.84M(-809.1%) | -$4.56M(-40.3%) | -$9.84M(-86.4%) |
| Sep 2014 | - | -$3.25M(-121.2%) | -$5.28M(-160.3%) |
| Jun 2014 | - | -$1.47M(-162.8%) | -$2.03M(-262.8%) |
| Mar 2014 | - | -$559.00K | -$559.00K |
| Dec 2013 | -$1.08M | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Cidara Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Cidara Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of CDTX is -$175.87M
What is the all-time high annual EBITDA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual EBITDA is -$1.08M
What is Cidara Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, CDTX annual EBITDA has changed by -$148.93M (-552.77%)
What is Cidara Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of CDTX is -$43.60M
What is the all-time high quarterly EBITDA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly EBITDA is $14.96M
What is Cidara Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, CDTX quarterly EBITDA has changed by -$26.27M (-151.54%)
What is Cidara Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of CDTX is -$159.75M
What is the all-time high TTM EBITDA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM EBITDA is -$559.00K
What is Cidara Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, CDTX TTM EBITDA has changed by -$114.22M (-250.90%)